In one paragraphReview in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Dominik ZawadzkiDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Natalia LibergalDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0009-0000-6201-6735 Jaśmina NowakDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Hanna GrzankaDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Maksymilian MikołajczykDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0009-0007-8021-2781 Mikołaj KisiałaDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0009-0005-2470-7996 Michał TulskiDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Wojciech KrajewskiDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Tomasz SzydełkoDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Bartosz MałkiewiczDepartment of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0000-0002-5933-3753 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
immunotherapymolecular pathogenesisrisk factorsrisk stratificationtargeted therapyupper tract urothelial carcinoma
Identifiers
PMID42588616
PMCPMC13465639
What OpenQuestion holds
Textmetadata
Read underepoch 390